The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MORPHEUS: A phase Ib/II multi-trial platform evaluating the safety and efficacy of cancer immunotherapy (CIT)-based combinations in patients (pts) with non-small cell lung cancer (NSCLC).
 
Melissa Lynne Johnson
Consulting or Advisory Role - Astellas Pharma (I); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Genentech/Roche (Inst); Otsuka (I)
Research Funding - Abbvie (Inst); Array BioPharma (Inst); AstraZeneca (Inst); BeiGene (Inst); BerGenBio (Inst); Boehringer Ingelheim (Inst); Checkpoint Therapeutics (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Foundation Medicine (Inst); Genmab (Inst); Guardant Health (Inst); Hengrui Pharmaceutical (Inst); Janssen (Inst); Kadmon (Inst); Lilly (Inst); Loxo (Inst); Lycera (Inst); Merck (Inst); Mersana (Inst); Mirati Therapeutics (Inst); Novartis (Inst); OncoMed (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Stem CentRx (Inst); Tarveda Therapeutics (Inst)
 
Benjamin J. Solomon
Honoraria - AstraZeneca; Bristol-Myers Squibb
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb (Inst); Eisai; Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Research Funding - Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Veristrat (Biodesix); UpToDate
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck; Novartis; Roche
 
Mark M. Awad
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Foundation Medicine; Genentech; Merck; Nektar; Novartis; Pfizer; Syndax
Research Funding - Bristol-Myers Squibb
 
Byoung Chul Cho
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Roche; Yuhan
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Roche; Yuhan
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis
Research Funding - AstraZeneca; Bayer; Novartis; Yuhan
 
Justin F. Gainor
Honoraria - ARIAD; Incyte; Merck; Novartis; Pfizer
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; Genentech; Loxo; Takeda; Theravance
Research Funding - Adaptimmune (Inst); ARIAD; AstraZeneca (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Genentech; Jounce Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Novartis (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Affymetrix
 
Sarah B. Goldberg
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly
Research Funding - AstraZeneca; Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Genentech (Inst); Immunogen (Inst); Kadmon (Inst); Merck (Inst); Pfizer (Inst); Pfizer (Inst)
 
Bhumsuk Keam
No Relationships to Disclose
 
Dae Ho Lee
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; CJ Healthcare; Janssen; Lilly; Merck; MSD; Mundipharma; Novartis; Ono Pharmaceutical; Pfizer; Roche; Samyan Biopharm
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; Mundipharma; Novartis; Pfizer; Samyang
 
Chen Huang
No Relationships to Disclose
 
Hans-Joachim Helms
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Hila Barak
Employment - Baxalta; Genentech/Roche
Stock and Other Ownership Interests - Roche/Genentech
Travel, Accommodations, Expenses - Baxalta; Genentech/Roche
 
Marcella Fasso
Employment - Roche/Genentech
Stock and Other Ownership Interests - Aduro BioTech; Roche/Genentech
 
Conrad Bleul
Employment - Roche/Genentech
Stock and Other Ownership Interests - Novartis
 
Edward Cha
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Naiyer A. Rizvi
Leadership - ARMO BioSciences
Stock and Other Ownership Interests - ARMO BioSciences; Gritstone Bio
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Janssen; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Regeneron